ResMed lifts Q3 earnings

Strong performances in Europe, Asia-Pacific drive growth for medical technology group.

Medical technology group ResMed (RMD) has lifted its third quarter earnings 6%, despite flat sales from its key United States market.

Australian-listed ResMed, which makes sleep disorder equipment, reported net income of $US89.97 million ($A97.20m) for the three months to March 31, up from $US85m a year ago.


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles